HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  


Search:



The Web

Rediff








Business
Portfolio Tracker
Business News
Specials
Columns
Market Report
Mutual Funds
Interviews
Tutorials
Message Board
Stock Talk



Home > Business > Corporate Headline > Quick Company Info

Risc

German Remedies Q3 net at Rs 3.39 cr

January 29, 2003 13:57 IST

German Remedies Ltd has posted a net profit of Rs 33.90 million for the quarter ended December 31, 2002 as compared to Rs 60.30 million for the quarter ended December 31, 2001. Total income (net of excise) has increased from Rs 473.50 million in DQ-01 to Rs 660.10 million in DQ-02.

The decline in profit was mainly due to exceptional items of expenditure charged against the income of the current year, both during the current quarter & nine months like VRS Payment etc made to the Andheri Plant employees, where the operations have been scaled down and additional expenses of the new divisions set up during the current year.

The board approved the merger of the company with Cadila Healthcare & also merger of Recon Healthcare Ltd, Zydus Pathline Ltd & Zoom Properties Ltd with Cadila Healthcare.

BSE Code: 500156

 

 



Article Tools

Email this Article

Printer-Friendly Format

Letter to the Editor



Related Stories


Cadila, German Remedies to merge

German Remedies, Cadila to merge



People Who Read This Also Read


Cadila, German Remedies tie up

RIL supports TRAI's telecom tariff







HOME   
   NEWS   
   BUSINESS   
   CRICKET   
   SPORTS   
   MOVIES   
   NET GUIDE   
   SHOPPING   
   BLOGS  
   ASTROLOGY  
   MATCHMAKER  
© 2003 rediff.com India Limited. All Rights Reserved.